Wegovy

Dec 08

December 8, 2024 By Irv Rubenstein

Part 1: GLP-1 Receptor Agonists: The New, Improved, and Not-Fully-Understood Weight Loss Drugs

Super-duper weight loss drugs (originally they were designed to help those with Type 2 diabetes, or T2D) like Ozempic, Wegovy, Mounjaro, et al. have swamped the marketplace because of their unique pharmacologic actions compared to their predecessors. Earlier weight loss drugs and over-the-counter concoctions (like coffee and other caffeine-derivatives, as well as smoking cigarettes, forRead More

Jan 11

January 11, 2024 By Irv Rubenstein

Weight Management’s New Look

Sometime over the past 30+ years, many in the medical and fitness world came to a difficult and exasperating conclusion: weight loss is not so simple as eat less, move more. For the past 50 years or so the estimated calculus of 3,500 calories = a pound of fat – that is, eat fewer caloriesRead More